Studies of gallbladder contraction using intramuscular sincalide

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Cholecystokinin (CCK) plays a vital role in gallbladder contraction.
• Sincalide, a synthetic octapeptide analog of CCK, is used to stimulate gallbladder function.
• Optimizing sincalide administration is crucial for diagnostic accuracy in cholecystography.

Purpose of the Study:

• To evaluate intramuscular sincalide as an agent for inducing gallbladder contraction.
• To compare the efficacy and side effect profiles of intramuscular versus intravenous sincalide administration.
• To assess the potential of intramuscular sincalide in cholecystokinin cholecystography.

Main Methods:

• 35 patients received intramuscular sincalide (two dosage groups) following oral cholecystography.
• 18 patients received intravenous sincalide.
• Six patients received an intramuscular placebo.

Main Results:

• Intramuscular sincalide demonstrated greater gallbladder contraction compared to intravenous administration.
• Generalized symptoms were more frequent with intravenous sincalide injection.
• Lower, sustained blood levels of sincalide after intramuscular injection may explain these findings.

Conclusions:

• Intramuscular sincalide is an effective agent for producing gallbladder contraction.
• Intramuscular administration of sincalide offers a potentially improved safety profile over intravenous use.
• Further research into intramuscular sincalide for cholecystokinin cholecystography is warranted.